Amid Japan crisis, hunt for better radiation care

Mar 28, 2011 By LAURAN NEERGAARD , AP Medical Writer

(AP) -- Japan's nuclear emergency highlights a big medical gap: Few treatments exist to help people exposed to large amounts of radiation.

But some possibilities are in the pipeline - development of drugs to treat poisoning, and the first rapid tests to tell who in a panicked crowd would really need them.

The U.S. calls these potential products "countermeasures," and they're part of the nation's preparations against a terrorist attack, such as a dirty bomb. But if they work, they could be useful in any kind of radiation emergency.

"Thinking of terrorist events is what drives us. Mother Nature can be much of a terror, too," says Dr. Robin Robinson, who heads the federal Biomedical Advanced Research and Development Authority, or BARDA, that funds late-stage research of products the government deems most likely to pan out.

BARDA has invested $164 million for research into anti-radiation treatment candidates since 2008, and $44 million for radiation testing - in hopes of adding such products to the nation's emergency medical stockpile soon. That's in addition to research dollars from the National Institutes of Health and the Defense Department.

Japan's crisis - where last week two nuclear plant workers were hospitalized for radiation burns - is sure to renew attention to a field that's long been overshadowed by the hunt for protections against bioterrorism, not radiological emergencies. Among the radiation projects considered farthest along in development:

-Rapid tests that could spot dangerous radiation doses with mere finger-pricks of blood. Already, a prototype machine sits at New York's Columbia University that could check thousands of people.

-Some drugs now used to help cancer patients boost their infection-fighting , sold under such names as Neupogen. They may do the same thing for radiation victims.

-An injection that saved monkeys from highly lethal beams. It seems to protect the body's two most radiation-sensitive spots, the bone marrow and lining of the gut.

Today, there are only a few proven therapies for radiation injuries. Good supportive care - lots of fluids, infusions of blood-clotting platelets, and infection-fighting antibiotics - is key for acute radiation syndrome, an overall poisoning that can begin causing symptoms days to weeks after a super-high exposure. To guard against longer-term harm, doses of potassium iodide can protect against future thyroid cancer by shielding the thyroid from one type of fallout, radioactive iodine. A few other treatments can help the body eliminate radioactive cesium and a few other isotopes.

Part of the challenge is radiation's variety of injuries - burns, bone marrow and gastrointestinal damage, lung scarring, the later-in-life cancer risk. Yet outside of an immediate blast zone where open wounds and burns make injury clear, there's no fast way to tell who got a huge dose.

Those Geiger counter-style monitors used on power-plant workers in Japan? They detect contamination on clothing or skin that might not enter the body, not what the body has absorbed, says medical physicist David Brenner, director of Columbia's Center for Radiological Research.

Moreover, previous emergencies have shown that sheer stress can cause nausea and diarrhea that mimic some early symptoms of radiation sickness in people who weren't exposed, he adds.

"Before you can start to treat people, you need to know what they got," Brenner says. "If you take a guess and get it wrong, you might do more harm than good."

So his team developed a way to detect early, DNA-based signs of radiation damage that estimated dose - using a drop of blood like diabetics use to test their blood sugar.

Brenner's team built a robotic machine named RABiT -- for "rapid automated biodosimetry tool" - that can analyze those bloodspots quickly. The eventual goal is to be able to test 30,000 blood samples in a day. Brenner is working with Northrop Grumman to make the machinery smaller, even portable.

Brenner says federal approval is still a few years away but that the prototype could be used in an emergency if health officials shipped blood samples to his lab.

What about treatments?

Cells in the bone marrow and GI tract are extremely vulnerable to radiation. They overreact to what should be reparable damage and commit cellular suicide, says Dr. Andrei Gudkov of the Roswell Park Cancer Institute.

Gudkov's team created a drug based on a protein from normal gut bacteria, named flagellin, that blocks some of the cellular destruction and also stimulates recovery of remaining cells. It dramatically improved the survival of monkeys treated up to 48 hours after they were zapped. And safety testing in 150 healthy people so far suggests the main side effect is a flulike reaction, Gudkov says. Cleveland BioLabs Inc. is doing further work needed for Food and Drug Administration evaluation.

BARDA's Robinson says that closest to the emergency stockpile may be those cancer drugs that spur growth of infection-fighting blood cells. Later this year, his agency will begin a push for research to prove they could work similarly in a radiation emergency.

"There isn't going to be a simple solution to any of this," cautions Dr. Nelson Chao of Duke University's countermeasures program, who also co-chairs the Radiation Injury Treatment Network. "There will be a lot of little steps to address the plethora of toxicities that come from radiation."

Explore further: Oil-swishing craze: Snake oil or all-purpose remedy?

More information: Columbia test: http://www.cmcr.columbia.edu/project1.html

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Drug mitigates toxic effects of radiation in mice

Jun 23, 2010

While radiation has therapeutic uses, too much radiation is damaging to cells. The most important acute side effect of radiation poisoning is damage to the bone marrow. The bone marrow produces all the normal blood cells, ...

Plant antioxidant may protect against radiation exposure

Sep 23, 2008

Resveratrol, the natural antioxidant commonly found in red wine and many plants, may offer protection against radiation exposure, according to a study by the University of Pittsburgh School of Medicine. When altered with ...

Recommended for you

Suddenly health insurance is not for sale

19 hours ago

(HealthDay)— Darlene Tucker, an independent insurance broker in Scotts Hill, Tenn., says health insurers in her area aren't selling policies year-round anymore.

Study: Half of jailed NYC youths have brain injury (Update)

19 hours ago

About half of all 16- to 18-year-olds coming into New York City's jails say they had a traumatic brain injury before being incarcerated, most caused by assaults, according to a new study that's the latest in a growing body ...

Autonomy and relationships among 'good life' goals

Apr 18, 2014

Young adults with Down syndrome have a strong desire to be self-sufficient by living independently and having a job, according to a study into the meaning of wellbeing among young people affected by the disorder.

User comments : 0

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday.

Health care site flagged in Heartbleed review

People with accounts on the enrollment website for President Barack Obama's signature health care law are being told to change their passwords following an administration-wide review of the government's vulnerability to the ...